article · Zenodo (CERN European Organization for Nuclear Research)
What this study adds: In this double-blind randomized controlled trial, intercostal bupivacaine infiltration reduced 24-hour postoperative morphine consumption by 34% (29 mg vs. 44 mg under placebo; p=0.04). It also significantly lowered pain scores at every assessment up to 48 hours, without increasing adverse events. Implications: This study validates a robust and accessible analgesic technique for patients undergoing thoracotomy in resource-limited settings. Its adoption could improve postoperative care standards, reduce reliance on systemic opioids and their side effects, and potentially shorten hospital stay. It calls for its integration into standard protocols and warrants cost-effectiveness studies. This publication is available in full in Health Sciences and Disease.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5281/zenodo.18218504
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.